The startup develops an ultrasensitive nanoarray analyzer that utilizes flow cytometry to digitally detect single proteins or nucleic acids through biomarker-linked nanoparticle complexes. This technology enables researchers to achieve single-molecule resolution in biomarker quantification, enhancing laboratory tests for disease prevention and promoting wellness.
Funding
$33M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current biomarker quantification methods often lack the sensitivity to detect subtle, early-stage biochemical changes, hindering timely disease prevention and wellness monitoring. Traditional assays may also suffer from limitations in reproducibility, dynamic range, and sample throughput, impacting the reliability and efficiency of laboratory testing.
Solution
Genotix Biotechnologies offers the DaVinci Liquid NanoArray Digital Analyzer, an ultrasensitive nanoarray analyzer that enables the digital detection and quantification of single proteins or nucleic acids. Utilizing the proprietary Liquid Nanoarray Digital Assay (LINARDA) technology, the DaVinci system employs flow cytometry to analyze biomarker-linked nanoparticle complexes at single-molecule resolution. This approach allows researchers to characterize and quantitate biomarkers with high accuracy and sensitivity, revealing early disease indicators and facilitating personalized medicine. The compact, user-friendly design of the DaVinci analyzer simplifies workflows and eliminates batch-related limitations, providing researchers with greater control and flexibility in their experiments.
Target Audience
The primary target audience includes researchers and scientists in biotechnology, pharmaceutical, and academic institutions who require highly sensitive and accurate biomarker quantification for disease research, drug discovery, and personalized medicine applications.
Features
- LINARDA technology for digital detection of single proteins or nucleic acids
- Flow cytometry analysis of biomarker-linked nanoparticle complexes
- Single-molecule resolution for ultrasensitive biomarker quantification
- Dynamic range: <10fg/mL up to 100ng/mL
- Coefficient of variation (CV) of <10% for highly reproducible assays
- Laser-based, digital quantitation for accurate and reliable results
- Individual/non-batch assay capability for flexible workflows
- Small sample volumes (< 10 μL) to preserve rare or limited samples
- Run time of < 1 minute/sample for efficient experimentation
- Compact footprint (43 cm x 39 cm x 28 cm, 18 kg)